Dna Group (T.R.) Balance Sheet Health
Financial Health criteria checks 6/6
Dna Group (T.R.) has a total shareholder equity of ₪79.2M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪80.7M and ₪1.5M respectively.
Key information
0%
Debt to equity ratio
₪0
Debt
Interest coverage ratio | n/a |
Cash | ₪66.70m |
Equity | ₪79.19m |
Total liabilities | ₪1.47m |
Total assets | ₪80.66m |
Financial Position Analysis
Short Term Liabilities: DNA's short term assets (₪66.9M) exceed its short term liabilities (₪685.0K).
Long Term Liabilities: DNA's short term assets (₪66.9M) exceed its long term liabilities (₪786.0K).
Debt to Equity History and Analysis
Debt Level: DNA is debt free.
Reducing Debt: DNA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DNA has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: DNA has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 18.6% each year